A new immunotherapy drug has demonstrated early promise in a recent prostate cancer clinical trial. The drug, called VIR-5500, is a "masked T-cell engager". This type of immunotherapy ignites our own ...
Researchers at Texas A&M Health have identified a molecular mechanism that increases cholesterol levels inside prostate ...
RNA cancer vaccines have the potential to significantly boost the immune system’s ability to fight and eliminate tumors.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results